Shares surged 7.7% in pre-market trading to $302.00 after Nova Ltd., the Israel-based company that makes precision measurement systems for chip factories, posted record third-quarter results and guided above Wall Street forecasts. The pop partially reverses a steep slide from $312.24 just a week ago — raising the question of whether the rally has lasting power or simply recovers lost ground.
Three Straight Record Quarters Signal Real Demand, Not a One-Off
Revenue hit $287.8 million, up 28% year over year and 13% quarter over quarter, driven by record sales into memory chips and advanced packaging.
Adjusted earnings of $2.86 per share beat the $2.77 consensus.
Management noted the company reached its $1 billion annual revenue milestone a year ahead of its five-year plan. For shareholders, that pace of execution compresses the timeline for profit growth and makes the current valuation — roughly 37× trailing earnings — easier to defend.
Guidance Tops Estimates, Pointing to Continued Acceleration
Nova expects Q4 earnings of $3.03–$3.18 per share on revenue of $305–$315 million.
The $310 million midpoint sits 1.9% above analysts' consensus. That matters because the market initially sold shares 5.7% after hours on November 5, suggesting traders wanted an even larger beat. The pre-market reversal implies broader semiconductor buying is now reinforcing the company-specific story.
Memory and Advanced Packaging Are Doing the Heavy Lifting
Record performance was "primarily driven by record revenue from the memory and advanced packaging segments, specifically DRAM and HBM applications."
The industry shift to a new transistor design called gate-all-around is expected to raise the amount of measurement needed per chip by roughly 30% — a structural tailwind that should boost Nova's revenue per factory for years. Service revenue also jumped about 50% year over year , adding a higher-margin, recurring income stream.
Margins Are Widening Faster Than Expected
Non-GAAP operating margin reached 35.5%, surpassing the company's own target range of 28%–33%.
Operating expenses grew only 15% while revenue rose 28% , showing the business is scaling efficiently. If Nova sustains this leverage into Q4's higher revenue base, annual profit growth could meaningfully outpace the top line.
With an average analyst price target near $515 — roughly 70% above today's price — Wall Street's consensus remains "Buy." The risk: any slowdown in chip-factory spending could stall this run as quickly as it started.